Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label trial of donepezil in vascular and mixed dementia.

Next Previous
X
Search
Trial Profile

An open-label trial of donepezil in vascular and mixed dementia.

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Donepezil (Primary)
  • Indications Dementia; Vascular dementia
  • Focus Therapeutic Use
  • Acronyms Vaspect
  • Sponsors Pfizer

    • Most Recent Events

    • 06 Nov 2019 Results presented at the 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
    • 12 Nov 2008 Status changed from completed to discontinued, as reported in ClinicalTrials.Gov record. The trial was terminated on 15 Oct 2007 citing recruitment difficulties and emphasising no safety or efficacy concerns regarding the study medication.
    • 25 Sep 2008 Actual patient number (149) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top